- Home
- DARE vs PMN Comparison
DARE vs PMN Comparison
Compare DARE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- PMN
- Stock Information
- Founded
- DARE N/A
- PMN 2004
- Country
- DARE United States
- PMN Canada
- Employees
- DARE N/A
- PMN N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- PMN Pharmaceuticals and Biotechnology
- Sector
- DARE Health Care
- PMN Health Care
- Exchange
- DARE Nasdaq
- PMN Nasdaq
- Market Cap
- DARE 31.9M
- PMN 33.7M
- IPO Year
- DARE N/A
- PMN N/A
- Fundamental
- Price
- DARE $3.34
- PMN $0.89
- Analyst Decision
- DARE Strong Buy
- PMN
- Analyst Count
- DARE 4
- PMN 0
- Target Price
- DARE $20.33
- PMN N/A
- AVG Volume (30 Days)
- DARE 37.5K
- PMN 53.0K
- Earning Date
- DARE 11-14-2024
- PMN 11-14-2024
- Dividend Yield
- DARE N/A
- PMN N/A
- EPS Growth
- DARE N/A
- PMN N/A
- EPS
- DARE N/A
- PMN N/A
- Revenue
- DARE $1,881,316.00
- PMN N/A
- Revenue This Year
- DARE N/A
- PMN N/A
- Revenue Next Year
- DARE $136.52
- PMN N/A
- P/E Ratio
- DARE N/A
- PMN N/A
- Revenue Growth
- DARE 88.13
- PMN N/A
- 52 Week Low
- DARE $2.67
- PMN $0.87
- 52 Week High
- DARE $7.56
- PMN $2.61
- Technical
- Relative Strength Index (RSI)
- DARE 52.30
- PMN 40.96
- Support Level
- DARE $3.03
- PMN $0.88
- Resistance Level
- DARE $3.38
- PMN $0.96
- Average True Range (ATR)
- DARE 0.12
- PMN 0.07
- MACD
- DARE 0.02
- PMN -0.01
- Stochastic Oscillator
- DARE 88.57
- PMN 4.04
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.